RNS Number : 3023P
IntelliAM AI PLC
02 July 2025
2 July 2025
IntelliAM AI Plc
('IntelliAM' or the 'Company')
First Order in USA from High-Quality Food Manufacturer
3-Site Programme
IntelliAM AI plc (AQSE: INT), the software company leveraging the power of AI and machine learning in the manufacturing industry, announces that it has received an order for IntelliAM AI platform services and sensor supplies from a high-quality food manufacturer in the USA for three of its major manufacturing sites.
The order provides for IntelliAM AI to supply software, technology support and sensors on-site which will enable the manufacturer to maximise its manufacturing efficiencies and return on investment. The work to install the IntelliAM AI systems and sensors will commence later this month. The order covers an initial period of 12 months.
Tom Clayton, CEO of IntelliAM AI, added: "This is an important new customer for IntelliAM and our first in the USA. Our respective teams have been working closely together to develop a bespoke programme of enhanced asset care deploying our AI and machine learning platforms for the three manufacturing sites."
ends
Enquiries:
|
|
IntelliAM AI plc Tom Clayton, Chief Executive Officer Daud Khan, Chief Financial Officer
|
+44 114 299 5007 |
Oberon Capital - AQSE Corporate Adviser and Broker Adam Pollock Mike Seabrook Jessica Cave
|
+44 203 179 5300 |
Square1 Consulting - Financial PR David Bick |
+44 207 929 5599 +44 7831 381201
|
About IntelliAM AI:
IntelliAM AI plc is a software company leveraging the power of AI and machine learning to transform productivity in the manufacturing and engineering sectors. The IntelliAM platform harnesses vast amounts of data from clients' machines and operational systems to provide actionable insights, enhancing productivity, reliability, supply-chain optimization, energy efficiency, and sustainability.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFLFERDRILIIE
;